Relay Therapeutics, Inc. (RLAY) Misses Q3 EPS by 1c

Relay Therapeutics, Inc. (NASDAQ: RLAY) reported Q3 EPS of ($0.43), $0.01 worse than the analyst estimate of ($0.42).

For earnings history and earnings-related data on Relay Therapeutics, Inc. (RLAY) click here.

You May Also Be Interested In

• BTIG Starts IQM Quantum Computers (IQMX) at Buy, PT $20
• Deutsche Bank Reiterates Buy Rating on Volkswagen AG (VOW:GR) (VWAGY)
• Citi lowers East West Bancorp price target to $152